checkAd
    Startseite > Aktien > Enanta Pharmaceuticals > Nachrichten
    Enanta Pharmaceuticals Aktie
    12,480
     
    USD
    -3,41 %
    -0,440 USD
    Letzter Kurs 02:00:00 Nasdaq
    12,480
     
    USD
    500 STK
    Geldkurs 25.04.24
    12,500
     
    USD
    200 STK
    Briefkurs 25.04.24
    ISIN: US29251M1062 · WKN: A1T7BJ · SYM: ENTA · USA

    Neueste Nachrichten

    Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
    17.04.24 · Business Wire (engl.) · Enanta Pharmaceuticals
    Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
    06.03.24 · Business Wire (engl.) · Enanta Pharmaceuticals
    Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4: 30 p.m. ET
    07.02.24 · Business Wire (engl.) · Enanta Pharmaceuticals
    Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
    06.02.24 · Business Wire (engl.) · Enanta Pharmaceuticals
    Enanta Pharmaceuticals to Host Conference Call on February 7 at 4: 30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023
    31.01.24 · Business Wire (engl.) · Enanta Pharmaceuticals
    Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference
    04.01.24 · Business Wire (engl.) · Enanta Pharmaceuticals
    Enanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    03.01.24 · Business Wire (engl.) · Enanta Pharmaceuticals
    Enanta Pharmaceuticals to Participate at Evercore ISI HealthCONx Conference
    22.11.23 · Business Wire (engl.) · Enanta Pharmaceuticals
    Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2023, with Webcast and Conference Call Today at 4: 30 p.m. ET
    20.11.23 · Business Wire (engl.) · Enanta Pharmaceuticals
    Enanta Pharmaceuticals to Host Conference Call on November 20 at 4: 30 p.m. ET to Discuss its Financial Results for its Fiscal Fourth Quarter and Full Year Ended September 30, 2023
    13.11.23 · Business Wire (engl.) · Enanta Pharmaceuticals
    Enanta Pharmaceuticals to Host Virtual Key Opinion Leader Event to Discuss Advances in the Treatment Landscape for Respiratory Syncytial Virus (RSV) and its Proprietary RSV Pipeline
    13.10.23 · Business Wire (engl.) · Enanta Pharmaceuticals
    Enanta Pharmaceuticals to Present Data for EDP-323, its Oral, Once-Daily, L-Protein Inhibitor in Development for the Treatment of Respiratory Syncytial Virus, at the 9th ESWI Influenza Conference
    17.09.23 · Business Wire (engl.) · Enanta Pharmaceuticals